Non-inferiority of 1 month versus longer dual antiplatelet therapy in patients undergoing PCI with drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials

AIM: The aim of this meta-analysis was to evaluate the safety of 1-month dual antiplatelet therapy (DAPT) followed by aspirin or a P2Y12 receptor inhibitor, after percutaneous coronary intervention (PCI) with drug-eluting stents (DES), based on the available evidence. METHODS: PubMed, MEDLINE, Embas...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajraktari, Gani, Bytyçi, Ibadete, Bajraktari, Artan, Henein, Michael Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118452/
https://www.ncbi.nlm.nih.gov/pubmed/35602665
http://dx.doi.org/10.1177/20406223221093758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118452/
https://www.ncbi.nlm.nih.gov/pubmed/35602665
http://dx.doi.org/10.1177/20406223221093758

Ejemplares similares